27 A total of 703 participants with uncontrolled T2DM (A1C of 7.09.5%) were randomized into four treatment groups that included a daily dose of either 3 mg, 7 mg, or 14 mg of oral semaglutide or placebo for 26 weeks
Beyond Lactobacillus and Bifidobacterium , several other taxonomic groups demonstrate significant therapeutic and industrial value ( Table 2 )
J Clin Pharm Ther (2017) 42(4):394403.10.1111/jcpt.12548 Summary Keywords riboflavin, Parkinsons disease, migraine, oxidative stress, glutamate excitotoxicity, pyridoxal phosphate, homocysteine, kynurenine Citation Marashly ET and Bohlega SA (2017) Riboflavin Has Neuroprotective Potential: Focus on Parkinsons Disease and Migraine
And with clinics across cities like Bangalore and Chennai, plus a free consult before you commit to anything, its a low-pressure way to see if its right for you